Carolyn Glass

Dr. Carolyn Glass


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
EEEmily Eichenberger
Emily Eichenberger
ACAmanda C. Coniglio
Amanda C. Coniglio
CMCarmelo Milano
Carmelo Milano
JSJacob Schroder
Jacob Schroder
BBBenjamin S. Bryner
Benjamin S. Bryner
CWCameron R. Wolfe
Cameron R. Wolfe

16 March 2022 in iScience
Verified
Journal Article
Open access
MBMuath Bishawi
Muath Bishawi
FLFranklin H. Lee
Franklin H. Lee
DADennis M. Abraham
Dennis M. Abraham
CGCarolyn Glass
Carolyn Glass
SBStephanie J. Blocker
Stephanie J. Blocker
DBDawn E. Bowles
Dawn E. Bowles
The complex and inaccessible space radiation environment poses an unresolved risk to astronaut cardiovascular health during long-term space exploration missions. To model this risk, healthy male c57BL/6 mice aged six months (corresponding to an astronaut of 34 years) were exposed to simplified galactic cosmic ray (GCR5-ion; 5-ion sim) irradiation at the NASA Space Radiation Laboratory (NSRL) at Brookhaven National Laboratories (BNL). Multi-modal cardiovascular functional assessments performed longitudinally and terminally revealed significant impairment in cardiac function in mice exposed to GCR5-ion compared to unirradiated controls, gamma irradiation, or single mono-energetic ions (56Fe or 16O). GCR5-ion-treated mice exhibited increased arterial elastance likely mediated by disruption of elastin fibers. This study suggests that a single exposure to GCR5-ion is associated with deterioration in cardiac structure and function that becomes apparent long after exposure, likely associated with increased morbidity and mortality. These findings represent important health considerations when preparing for successful space exploration.

3 July 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
Fiorella CalabreseFiorella Calabrese
Fiorella Calabrese
ARAnja C. Roden
Anja C. Roden
EPElizabeth Pavlisko
Elizabeth Pavlisko
FLFrancesca Lunardi
Francesca Lunardi
DNDesley Neil
Desley Neil
ARAntoine Roux
Antoine Roux
Routine monitoring of lung-transplanted patients is crucial for the identification of immunological and non-immunological complications. Determining the etiology of acute allograft dysfunction, particularly in alloimmune-mediated disorders, relies heavily on the lung biopsy with histopathologic analysis. Standardization of the pathologic diagnosis of rejection (e.g., cellular and antibody-mediated) is based on consensus statements and guidelines, indicating the importance of a multidisciplinary approach to achieve a definitive etiological diagnosis. In addition to these statements and guidelines, refinements and standardizations are feasible through systematic analysis morphological, immunophenotypic and molecular alterations observed in transbronchial biopsies. This study is to identify key morphologic features to be assessed, select consistent and reproducible terminology for each histological feature, and provide standardized definitions for pathological assessment and grading. A template was created by experts in lung transplantation including pathologists, pulmonologists, immunologists. An initial draft was circulated, followed by discussions and multiple revisions by email and conference calls. The "lung allograft standardized histological analysis - LASHA" template was created and structured as multiple-choice questions with number of fields to be filled in to allow for standardization of results and easy transfer into a future electronic spreadsheet. This template will help facilitate multicenter studies through a uniform protocol and correlations with new diagnostic modalities. After validation in large-scale studies, an optimized template could be included in routine clinical practice to enhance graft assessment and medical decision-making.

1 September 2021 in Cardiovascular Pathology
Verified
Journal Article
Closed access
MBMuath Bishawi
Muath Bishawi
DBDawn Bowles
Dawn Bowles
MPMichelle Mendiola Pla
Michelle Mendiola Pla
FOFaye Oakes
Faye Oakes
YCYuting Chiang
Yuting Chiang
CGCarolyn Glass
Carolyn Glass

1 April 2020 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
WDWei Deng
Wei Deng
HLHongliang Liu
Hongliang Liu
SLSheng Luo
Sheng Luo
JCJeffrey Clarke
Jeffrey Clarke
CGCarolyn Glass
Carolyn Glass
QWQingyi Wei
Qingyi Wei
Background: Several oncogenic signals are involved in the synthesis, metabolism, transportation, and modulation of cholesterol. However, the roles of genetic variants of the cholesterol pathway genes in cancer survival remain unclear.Methods: We investigated associations between 26,781 common SNPs in 209 genes of the cholesterol pathway and non–small cell lung cancer (NSCLC) survival by utilizing genotyping data from two published genome-wide association studies. We used multivariate Cox proportional hazards regression and expression quantitative trait loci analyses to identify survival-associated SNPs and their correlations with the corresponding mRNA expression, respectively. We also used the Kaplan–Meier survival analysis and bioinformatics functional prediction to further evaluate the identified independent SNPs.Results: We found five independent SNPs (APOB rs1801701C>T; CDH13 rs35859010 C>T, rs1833970 T>A, rs254315 T>C, and rs425904 T>C) to be significantly associated with NSCLC survival in both discovery and replication datasets. When the unfavorable genotype (APOB rs1801701CC) and haplotypes (CDH13 rs35859010-rs1833970-rs254315-rs425904 C-A-T-C and T-T-T-T) were combined into a genetic score as the number of unfavorable genotypes/haplotypes (NUGH) in the multivariate analysis, an increased NUGH was associated with worse survival (Ptrend < 0.0001). In addition, both APOB rs1801701T<C and CDH13 rs425904C<T were correlated with mRNA expression of the genes in normal lung tissues from the genotype-tissue expression project.Conclusions: Genetic variants of APOB and CDH13 in the cholesterol pathway were associated with NSCLC survival, possibly by affecting their gene expression.Impact: Genetic variants of APOB and CDH13 in the cholesterol pathway may provide new scientific insights into NSCLC prognosis.

1 February 2022 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
CGCarolyn Glass
Carolyn Glass
KLKyle J. Lafata
Kyle J. Lafata
WJWilliam Jeck
William Jeck
RHRoarke Horstmeyer
Roarke Horstmeyer
CCColin Cooke
Colin Cooke
MSMichael A. Seidman
Michael A. Seidman